# Biomarker-based Prognostic Assessment

> **NCT04044066** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 10000 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Stable Angina

## Interventions

- **BIOLOGICAL:** Plasma biomarker

## Key facts

- **NCT ID:** NCT04044066
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-09
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04044066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04044066, "Biomarker-based Prognostic Assessment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04044066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*